QINLOCK

deciphera pharmaceuticals. llc🇨🇦 Health Canada

Approval Id: ef094fe801a03b4c
Drug Approval Canada Name: QINLOCK
Product Name: QINLOCK
Status: Marketed
Status Date: 2020-12-10
Original Market Date: 2020-12-10
Din: 02500833
Drug Class: Human
Dosage Form: Tablet
Route Of Administration: Oral
Schedule: Prescription
Ahfs: 10:00.00
Atc Original: L01EX19 RIPRETINIB
Atc Name: l 01 ex 19
Aig Number: 0162315001
Company Name: deciphera pharmaceuticals. llc
Company Address: 200 Smith Street, Waltham, Massachusetts, United States, 02451

RIPRETINIB

50 MG

Authorized

Agency

Health Canada

Country

🇨🇦

Approval Date

Jul 4, 2025

Approval ID

ef094fe801a03b4c

Type

Standard